Veterinary drug · Drug monograph
Yohimbine: veterinary dose and monograph
Yohimbine is a veterinary drug. Alpha-2 adrenergic ANTAGONIST used as a reversal agent — it rapidly antagonises xylazine (and other alpha-2 agonist) sedation/anaesthesia, and is the classic antidote for amitraz (the alpha-2-agonist tick dip/collar) toxicosis. Indications include reversal of xylazine sedation/anaesthesia (dogs, ruminants, horses, wildlife); amitraz toxicosis — antidote (reverses CNS depression, bradycardia, hyperglycaemia); reversal of other alpha-2 agonist overdose (alternative to atipamezole). This monograph lists 8 reference doses for dogs, cats, cattle, horses, sheep and birds and 2 more species, each with route, frequency and source, plus meat and milk withdrawal periods for food animals.
At a glance
- Drug class
- Veterinary drug
- Also known as
- Yobine, Antagonil, Yohimbine hydrochloride
- Species with doses
- Dogs, Cats, Cattle, Horses, Sheep, Birds, Rabbits and Camelids
- General dose range
- 0.1–0.125 mg/kg IV single dose (repeat if needed) — check the species tables for the indication
- Routes
- IV
- Last reviewed
- 1 October 2026
Indications
- Reversal of xylazine sedation/anaesthesia (dogs, ruminants, horses, wildlife)
- Amitraz toxicosis — antidote (reverses CNS depression, bradycardia, hyperglycaemia)
- Reversal of other alpha-2 agonist overdose (alternative to atipamezole)
Yohimbine dose by species
Doses are per administration unless stated. mg/kg doses scale with body weight; per-animal, per-quarter and infusion-rate doses are shown as the reference writes them.
Dogs
| Indication | Dose | Route | Frequency | Duration |
|---|---|---|---|---|
| Xylazine reversal / amitraz toxicosis | 0.1–0.11 mg/kg | IV | single dose (repeat per amitraz protocol) | — |
- Xylazine reversal / amitraz toxicosis: Papich 5e: 0.11 mg/kg IV, or 0.25–0.5 mg/kg SC or IM. Plumb’s p.1179: xylazine reversal 0.1–0.11 mg/kg IV slowly (label); medetomidine 0.11 mg/kg IV; amitraz — 0.1 mg/kg IV repeated as needed (Manning; Hillier), or 0.11 mg/kg IV / 0.25 mg/kg IM with atipamezole 50 µg/kg IM (Torres 2007).
Cats
| Indication | Dose | Route | Frequency | Duration |
|---|---|---|---|---|
| Xylazine reversal | 0.11 mg/kg | IV | single dose | — |
- Xylazine reversal: Papich 5e (dogs and cats): 0.11 mg/kg IV slowly, or 0.25–0.5 mg/kg SC or IM. (The previous 0.1–0.5 mg/kg IV mixed the IV and IM doses.)
Cattle
| Indication | Dose | Route | Frequency | Duration | Withdrawal |
|---|---|---|---|---|---|
| Xylazine reversal | 0.1–0.2 mg/kg | IV | single dose | — | Withdrawal NOT established — treat as extra-label |
- Xylazine reversal: Papich 5e: cattle and sheep 0.125–0.2 mg/kg IV to reverse xylazine or medetomidine. Plumb’s p.1179: 0.125 mg/kg IV (Gross & Tranquilli); IM preferred except in emergencies (less excitement), 0.1 mg/kg IV in emergencies — wait 30–45 min after IM ketamine/Telazol before reversing (Anderson & Abrahamsen 2008). Obtain a FARAD withdrawal.
Horses
| Indication | Dose | Route | Frequency | Duration |
|---|---|---|---|---|
| Xylazine reversal | 0.075–0.125 mg/kg | IV | single dose | — |
- Xylazine reversal: Plumb’s p.1179 (Gross & Tranquilli): 0.075 mg/kg IV. Papich 5e: 0.125 mg/kg IV for xylazine, 0.2 mg/kg IV for detomidine; the full dose may not be needed. Give slowly. ARCI Class 2.
Sheep
| Indication | Dose | Route | Frequency | Duration | Withdrawal |
|---|---|---|---|---|---|
| Xylazine reversal | 0.125–0.2 mg/kg | IV | single, slow | — | Withdrawal NOT established — treat as extra-label |
- Xylazine reversal: Papich 5e: cattle and sheep 0.125–0.2 mg/kg IV to reverse xylazine or medetomidine. Give slowly; atipamezole is an alternative.
Buffalo
No buffalo-specific doses are on file, so buffalo are dosed as cattle.
| Indication | Dose | Route | Frequency | Duration | Withdrawal |
|---|---|---|---|---|---|
| Xylazine reversal | 0.1–0.2 mg/kg | IV | single dose | — | Withdrawal NOT established — treat as extra-label |
- Xylazine reversal: Papich 5e: cattle and sheep 0.125–0.2 mg/kg IV to reverse xylazine or medetomidine. Plumb’s p.1179: 0.125 mg/kg IV (Gross & Tranquilli); IM preferred except in emergencies (less excitement), 0.1 mg/kg IV in emergencies — wait 30–45 min after IM ketamine/Telazol before reversing (Anderson & Abrahamsen 2008). Obtain a FARAD withdrawal.
Birds
| Indication | Dose | Route | Frequency | Duration |
|---|---|---|---|---|
| Alpha-2 agonist reversal | 0.1 mg/kg | IV | once | — |
- Alpha-2 agonist reversal: Plumb’s p.1179 (Clyde & Paul-Murphy 2000): 0.1 mg/kg IV.
Rabbits
| Indication | Dose | Route | Frequency | Duration |
|---|---|---|---|---|
| Xylazine reversal | 0.2 mg/kg | IV | as needed | — |
- Xylazine reversal: Plumb’s p.1179 (Huerkamp 1995): rabbits 0.2 mg/kg IV as needed; also partially antagonises ketamine and acepromazine. Mice/rats 0.2 mg/kg IP.
Camelids
| Indication | Dose | Route | Frequency | Duration |
|---|---|---|---|---|
| Xylazine reversal | 0.25 mg/kg | IV | once | — |
- Xylazine reversal: Plumb’s p.1179 (Fowler 1989): llamas 0.25 mg/kg IV or IM.
Contraindications
Known hypersensitivity. Caution in seizure disorders, significant cardiac disease and hypertension (alpha-2 blockade raises sympathetic outflow → tachycardia, hypertension, excitement). Renal disease. Avoid rapid IV (transient excitement/cardiovascular effects).
Species-specific warnings
Cattle: Ruminants are exquisitely sensitive to xylazine; yohimbine is useful to hasten recovery from over-sedation.
Adverse effects
- Transient excitement/apprehension, muscle tremor
- Tachycardia, hypertension
- Hypersalivation
- Rapid reversal can unmask pain (if the alpha-2 was providing analgesia)
Drug interactions
- Alpha-2 agonists (xylazine, medetomidine, amitraz, clonidine): directly antagonised (the intended action) — reverses their effects
- Other sympathomimetics/stimulants: additive excitation, tachycardia, hypertension
- Tricyclic antidepressants/MAOIs: enhanced pressor effects
Pregnancy and lactation
Limited data; use when reversal is clinically needed. Rapid reversal in a pregnant animal should be balanced against the cardiovascular surge it produces.
Monitoring
- Recovery from sedation (arousal, posture, gait)
- Heart rate, rhythm and blood pressure (watch the post-reversal surge)
- For amitraz toxicosis: re-emergence of CNS depression/bradycardia (amitraz outlasts yohimbine — re-dose) and blood glucose
- Pain status if the alpha-2 was providing analgesia
Toxicity and overdose
Overdose causes sympathetic overstimulation — excitement/agitation, muscle tremor, tachycardia, hypertension and potentially seizures. Effects are generally short-lived because yohimbine is rapidly metabolised (which is also why repeat dosing is needed for the longer-acting amitraz).
Management: No specific antidote. Supportive — keep calm/quiet, IV fluids, and manage tachyarrhythmia/hypertension and seizures (benzodiazepines) as needed. Effects wane quickly with the drug's short half-life.
Clinical pearls
- The classic reverser for XYLAZINE — and the go-to antidote for AMITRAZ (tick dip/collar) toxicosis
- Amitraz lasts longer than a single yohimbine dose — expect signs to recur and be ready to re-dose plus give supportive care
- For medetomidine/dexmedetomidine, atipamezole is the more selective, usually preferred reversal agent
- Give slowly IV — rapid injection causes transient excitement, tachycardia and hypertension
- Reversal also reverses the alpha-2's analgesia — provide alternative pain relief if a painful procedure was performed
Mechanism of action
Competitive antagonist at alpha-2 adrenoceptors. By blocking central (pre-synaptic) alpha-2 receptors it removes the negative feedback on noradrenaline release, increasing central sympathetic outflow and arousal — thereby reversing the sedation, bradycardia and CNS/respiratory depression produced by alpha-2 agonists such as xylazine and amitraz. It also has some peripheral alpha-2-blocking and serotonergic activity.
Formulations and products
- Injection 2 mg/mL
- Yobine / Antagonil (Lloyd / various) — 2 mg/mL, Injection
Storage
Injection: 15–30 °C, protect from light.
Before you use this dose
Reference doses for veterinary professionals. Confirm the dose against the product label, the patient’s condition, current guidance and local regulations before use; the attending veterinarian remains responsible for every clinical decision.
Frequently asked questions
What is the dose of Yohimbine for dogs?
Reference doses for Yohimbine in dogs: 0.1–0.11 mg/kg IV single dose (repeat per amitraz protocol) (Xylazine reversal / amitraz toxicosis). Confirm against the label and the patient before use.
What is the dose of Yohimbine for cats?
Reference doses for Yohimbine in cats: 0.11 mg/kg IV single dose (Xylazine reversal). Confirm against the label and the patient before use.
What is the dose of Yohimbine for cattle?
Reference doses for Yohimbine in cattle: 0.1–0.2 mg/kg IV single dose (Xylazine reversal). Confirm against the label and the patient before use.
What is the withdrawal period for Yohimbine?
Cattle, IV (Xylazine reversal): Withdrawal NOT established — treat as extra-label; Sheep, IV (Xylazine reversal): Withdrawal NOT established — treat as extra-label. Follow the product label and national regulations where they differ.
When should Yohimbine not be used?
Known hypersensitivity. Caution in seizure disorders, significant cardiac disease and hypertension (alpha-2 blockade raises sympathetic outflow → tachycardia, hypertension, excitement). Renal disease. Avoid rapid IV (transient excitement/cardiovascular effects).
What are the side effects of Yohimbine in animals?
Transient excitement/apprehension, muscle tremor; Tachycardia, hypertension; Hypersalivation; Rapid reversal can unmask pain (if the alpha-2 was providing analgesia).
Sources
- Plumb's Veterinary Drug Handbook
- Merck Veterinary Manual, 11th edition
- Papich, Papich Handbook of Veterinary Drugs, 5th edition
Last reviewed · VetMasterJi